Rare diseases
Investigational molecules
Locations
345 conditions with trials, the busiest first
956 trials across Europe, recruiting first
Study on the Use of 18F-PSMA-1007 PET/MRI for Diagnosing Significant Prostate Cancer in Patients with Suspected Prostate Cancer
ItalyStudy Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer
GermanyStudy on HPV Vaccine After Treatment for High-Grade Cervical Lesions in Women Over 45
FranceStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy
BelgiumStudy on Infertility: Effects of Choriogonadotropin Alfa, Nomegestrol Acetate, Estradiol Hemihydrate, and Progesterone in Patients Undergoing Frozen Embryo Transfer
SpainStudy on the Safety and Effectiveness of Platelet Concentrate for Women with Low Ovarian Reserve
SpainStudy on the Effects of Tinzaparin on Biomarkers in Advanced Ovarian Cancer Patients Receiving Chemotherapy
SwedenStudy on Docetaxel, Cabazitaxel, and Darolutamide for Men with Metastatic Castration-Resistant Prostate Cancer
The NetherlandsStudy on the Use of Sulfur Hexafluoride in Ultrasound for Diagnosing Adnexal Torsion in Patients with Suspected Ovarian Twisting
FranceStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
BulgariaEffect of linzagolix and bilastine on breast density in premenopausal women at high risk of breast cancer: a phase II trial
SpainPhase 2 Study of Trastuzumab Deruxtecan plus Bevacizumab versus Standard Chemotherapy in Patients with Recurrent Ovarian Cancer after PARP Inhibitor Therapy
SpainThe therapies tested most often in Reproductive system and breast disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
